Sevaro Health, a pioneer in transforming neurological care across the United States, has successfully closed an oversubscribed $39 million Series B funding round.
The round was led by Valtruis, an investment platform from Welsh, Carson, Anderson & Stowe dedicated to advancing next-generation healthcare solutions, and Intermountain Ventures, the innovation fund of Intermountain Health. Early investors APA and Catalyst also participated, reinforcing confidence in Sevaro’s scalable care model.
Amid rising patient demand, hospital staffing shortages, and a growing shift toward value-based care, Sevaro offers a proven approach that balances clinical excellence with financial sustainability. The new capital will accelerate the company’s innovation initiatives, deepen system integrations, and expand its hybrid workforce model to better serve hospital partners.
“Sevaro has built something unique a scalable model for virtual neuroscience backed by proven results,” said Anna Haghgooie, Managing Partner at Valtruis. “They’re giving hospitals the resources needed to deliver advanced care to communities, without compromise.”
Central to Sevaro’s model is Synapse AI, an advanced platform that connects hospital teams with virtual specialists across the entire patient journey. Beyond acute neurology and neurohospitalist services, Sevaro drives clinical innovation by developing turnkey Virtual Institutes of Neuroscience Excellence. As one of the first organizations to provide care across the full continuum from ambulance to ambulatory care Sevaro delivers virtual neurology clinics, physical medicine and rehabilitation services, lifestyle coaching, and fully coordinated care solutions.
Also Read: Commure Ambient AI in MEDITECH Expanse Enables Mobile Docs
Sevaro’s proven approach in neurological care is now expanding into multiple specialties. Its hybrid model supports flexible coverage in neurology and additional disciplines, including hospitalist medicine, cardiology, infectious disease, behavioral health, surgery, neurosurgery, and neurointerventional radiology.
For hospitals, Synapse AI functions as an extension of the existing workforce, helping prevent coverage gaps, reduce clinician burnout, and provide reliable backup coverage through streamlined workflow automation. Health systems partnering with Sevaro have reported measurable outcomes, including over $4 million saved in the first year by increasing virtual neurology access and reducing unnecessary patient transfers. Partners also note an average response time of 25 seconds to reach a neurologist, improved referrals, and higher provider satisfaction.
“This funding validates what we’ve believed from day one, that hospitals deserve a model where quality and financial performance go hand in hand,” said Dr. Rajiv Narula, Founder and CEO of Sevaro Health. “Synapse AI isn’t just a solution for coverage, it’s our commitment to building the future of specialty care where physicians are proud to practice, and every patient in the world receives the care they deserve.”
The Series B investment coincides with Sevaro’s leadership expansion, including the appointment of Jason Bond as CFO and SVP of Strategy. Bond brings extensive experience from Mount Sinai, Yale New Haven Health, and CityMD, with deep expertise in health system finance, mergers and acquisitions, and value-based care.
